Clinical Trials Directory

Trials / Completed

CompletedNCT04896645

Albuterol Integrated Adherence Monitoring in Children With Asthma

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Children's Hospital Los Angeles · Academic / Other
Sex
All
Age
8 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The investigators propose to evaluate whether an integrated electronic adherence monitoring albuterol rescue inhaler can improve proper use in a mostly minority and inner-city population of children treated for asthma at the Children's Hospital of Los Angeles

Detailed description

This study is designed to (1) determine whether an integrated EAM albuterol rescue inhaler can increase proper use (2) determine if the monitoring capabilities of the device (flow rate, warnings) and/or increased proper use from having the device correlate with better outcomes. The investigators will also have patients perform at-home gamified spirometry (Aluna ©) to (3) determine if at-home spirometry can predict albuterol use or change outcomes.

Conditions

Interventions

TypeNameDescription
DEVICEDigihaler Albuterol Device by TEVAPatient with asthma will have their regular albuterol rescue inhaler replaced with Digihaler, they will also be asked to perform gamified spirometry (Aluna) at home

Timeline

Start date
2021-06-01
Primary completion
2022-06-22
Completion
2022-06-22
First posted
2021-05-21
Last updated
2023-11-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04896645. Inclusion in this directory is not an endorsement.